Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study.

Muratov S, Lee J, Holbrook A, Guertin JR, Mbuagbaw L, Paterson JM, Gomes T, Pequeno P, Tarride JE.

BMJ Open. 2019 Oct 28;9(10):e028637. doi: 10.1136/bmjopen-2018-028637.

2.

Unplanned index hospital admissions among new older high-cost health care users in Ontario: a population-based matched cohort study.

Muratov S, Lee J, Holbrook A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Pequeno P, Tarride JE.

CMAJ Open. 2019 Aug 25;7(3):E537-E545. doi: 10.9778/cmajo.20180185. Print 2019 Jul-Sep.

3.

Frailty and health services use among Quebec seniors with non-hip fractures: a population-based study using adminsitrative databases.

Fillion V, Sirois MJ, Gamache P, Guertin JR, Morin SN, Jean S.

BMC Health Serv Res. 2019 Jan 25;19(1):70. doi: 10.1186/s12913-019-3865-z.

4.

Just how much does it cost? A cost study of chronic pain following cardiac surgery.

Guertin JR, Pagé MG, Tarride JÉ, Talbot D, Watt-Watson J, Choinière M.

J Pain Res. 2018 Nov 8;11:2741-2759. doi: 10.2147/JPR.S175090. eCollection 2018.

6.

Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study.

Muratov S, Lee J, Holbrook A, Costa A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Tarride JE.

BMC Geriatr. 2018 Nov 1;18(1):262. doi: 10.1186/s12877-018-0952-7.

7.

Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk.

Mitchell D, Guertin JR, LeLorier J.

Mol Diagn Ther. 2018 Dec;22(6):641-652. doi: 10.1007/s40291-018-0356-6.

PMID:
30218425
8.

Body-mass index and metastatic melanoma outcomes.

Nabi H, Guertin JR, Talbot D, Diorio C.

Lancet Oncol. 2018 May;19(5):e226. doi: 10.1016/S1470-2045(18)30287-0. No abstract available.

PMID:
29726385
9.

A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.

Mitchell D, Guertin JR, Dubois A, Dubé MP, Tardif JC, Iliza AC, Fanton-Aita F, Matteau A, LeLorier J.

Mol Diagn Ther. 2018 Apr;22(2):241-254. doi: 10.1007/s40291-018-0323-2.

PMID:
29651791
10.

Effectiveness of a Type 2 Diabetes Screening Intervention in the Canadian Workplace.

Tarride JE, Smofsky A, Nykoliation P, Allain S, Lewis-Daly L, Satok D, Schwartz J, Pollack JH, Guertin JR, McIntyre RS.

Can J Diabetes. 2018 Oct;42(5):493-499.e1. doi: 10.1016/j.jcjd.2017.12.008. Epub 2017 Dec 18.

11.

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada.

Tarride JE, Hopkins RB, Burke N, Guertin JR, O'Reilly D, Fell CD, Dion G, Kolb M.

Clinicoecon Outcomes Res. 2018 Feb 22;10:127-137. doi: 10.2147/CEOR.S154323. eCollection 2018.

12.

Age- and sex-specific Canadian utility norms, based on the 2013-2014 Canadian Community Health Survey.

Guertin JR, Feeny D, Tarride JE.

CMAJ. 2018 Feb 12;190(6):E155-E161. doi: 10.1503/cmaj.170317.

13.

Senior high-cost healthcare users' resource utilization and outcomes: a protocol of a retrospective matched cohort study in Canada.

Muratov S, Lee J, Holbrook A, Paterson JM, Guertin JR, Mbuagbaw L, Gomes T, Khuu W, Pequeno P, Costa AP, Tarride JE.

BMJ Open. 2017 Dec 26;7(12):e018488. doi: 10.1136/bmjopen-2017-018488.

14.

Preliminary Results of the Adoption and Application of the Integrated Comprehensive Care Bundle Care Program When Treating Patients with Chronic Obstructive Pulmonary Disease.

Guertin JR, Bowen JM, Gosse C, Blackhouse G, O'Reilly DJ, Baltaga E, Cox G, Johnson D, Le Blanc B, Loncke J, Pugsley S, Sivakumaran R, Wheatley L, Smith K, Tarride JE.

Can Respir J. 2017;2017:7049483. doi: 10.1155/2017/7049483. Epub 2017 Aug 7.

15.

Screening for atrial fibrillation in Canadian pharmacies: an economic evaluation.

Tarride JE, Dolovich L, Blackhouse G, Guertin JR, Burke N, Manja V, Grinvalds A, Lim T, Healey JS, Sandhu RK.

CMAJ Open. 2017 Aug 22;5(3):E653-E661. doi: 10.9778/cmajo.20170042.

16.

Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized Data.

Guertin JR, Bowen JM, De Rose G, O'Reilly DJ, Tarride JE.

MDM Policy Pract. 2017 Mar 16;2(1):2381468317697711. doi: 10.1177/2381468317697711. eCollection 2017 Jan-Jun.

17.

Erratum to: The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status.

Tarride JE, Breau R, Sharma AM, Hong D, Gmora S, Guertin JR, O'Reilly D, Xie F, Anvari M.

Obes Surg. 2017 Apr;27(4):1128. doi: 10.1007/s11695-017-2598-5. No abstract available.

PMID:
28194653
18.
19.

Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin.

Mitchell D, Guertin JR, Iliza AC, Fanton-Aita F, LeLorier J.

Mol Diagn Ther. 2017 Feb;21(1):95-105. doi: 10.1007/s40291-016-0238-8.

20.

A model to assess the cost-effectiveness of pharmacogenomics tests in chronic heart failure: the case of ivabradine.

Iliza AC, Matteau A, Guertin JR, Mitchell D, Fanton-Aita F, Dubois A, Dubé MP, Tardif JC, LeLorier J.

Pharmacogenomics. 2016 Oct;17(15):1693-1706. Epub 2016 Oct 10.

PMID:
27719379
21.

Maximal expected benefits from lowering cholesterol in primary prevention for a high-risk population.

Fanton-Aita F, Matteau A, Iliza AC, Mitchell D, Guertin JR, Dubois A, Dubé MP, Tardif JC, LeLorier J.

Curr Med Res Opin. 2016 Dec;32(12):1955-1958. Epub 2016 Sep 20.

PMID:
27648984
22.

Performance of the high-dimensional propensity score in adjusting for unmeasured confounders.

Guertin JR, Rahme E, LeLorier J.

Eur J Clin Pharmacol. 2016 Dec;72(12):1497-1505. Epub 2016 Aug 30.

23.

The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status.

Tarride JE, Breau R, Sharma AM, Hong D, Gmora S, Guertin JR, O'Reilly D, Xie F, Anvari M.

Obes Surg. 2017 Feb;27(2):349-356. doi: 10.1007/s11695-016-2298-6. Erratum in: Obes Surg. 2017 Apr;27(4):1128.

PMID:
27503212
24.

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods.

Guertin JR, Rahme E, Dormuth CR, LeLorier J.

BMC Med Res Methodol. 2016 Feb 19;16:22. doi: 10.1186/s12874-016-0119-1.

25.

Bias within economic evaluations - the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug.

Guertin JR, Mitchell D, Ali F, LeLorier J.

Clinicoecon Outcomes Res. 2015 Oct 6;7:497-503. doi: 10.2147/CEOR.S90386. eCollection 2015.

26.

Cost effectiveness of 'on demand' HIV pre-exposure prophylaxis for non-injection drug-using men who have sex with men in Canada.

Ouellet E, Durand M, Guertin JR, LeLorier J, Tremblay CL.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):23-9.

27.

Challenge of informing patient decision making: what can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-of-life issues?

Boothroyd LJ, Lambert LJ, Ducharme A, Guertin JR, Sas G, Charbonneau É, Carrier M, Cecere R, Morin JE, Bogaty P.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):179-87. doi: 10.1161/CIRCOUTCOMES.113.000243. Epub 2014 Jan 14. Review. No abstract available.

PMID:
24425705
28.

Should eligibility for heart transplantation be a requirement for left ventricular assist device use? Recommendations based on a systematic review.

Boothroyd LJ, Lambert LJ, Sas G, Guertin JR, Ducharme A, Charbonneau É, Carrier M, Cecere R, Morin JE, Bogaty P.

Can J Cardiol. 2013 Dec;29(12):1712-20. doi: 10.1016/j.cjca.2013.05.014. Epub 2013 Aug 23. Review.

PMID:
23978595
29.

Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs. rate-control strategies.

Poulin F, Khairy P, Roy D, Levesque S, Talajic M, Guertin JR, Lelorier J; Atrial Fibrillation and Congestive Heart Failure Trial Investigators.

Can J Cardiol. 2013 Oct;29(10):1256-62. doi: 10.1016/j.cjca.2013.03.005. Epub 2013 Jun 7.

PMID:
23751149
30.

Transcatheter aortic valve implantation: recommendations for practice based on a multidisciplinary review including cost-effectiveness and ethical and organizational issues.

Boothroyd LJ, Spaziano M, Guertin JR, Lambert LJ, Rodés-Cabau J, Noiseux N, Nguyen M, Dumont É, Carrier M, de Varennes B, Ibrahim R, Martucci G, Xiao Y, Morin JE, Bogaty P.

Can J Cardiol. 2013 Jun;29(6):718-26. doi: 10.1016/j.cjca.2012.09.002. Epub 2012 Dec 4. Review.

PMID:
23218465
31.

Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea.

Kamdeu Fansi AA, Guertin JR, LeLorier J.

J Med Econ. 2012;15(1):53-60. doi: 10.3111/13696998.2011.629015. Epub 2011 Oct 24. Erratum in: J Med Econ. 2012;15(1):205.

PMID:
22023067
32.

Atrial fibrillation: a real-life observational study in the Québec population.

Guertin JR, Dorais M, Khairy P, Sauriol L, Matteau A, Poulin F, Talajic M, Roy D, LeLorier J.

Can J Cardiol. 2011 Nov-Dec;27(6):794-9. doi: 10.1016/j.cjca.2011.03.009. Epub 2011 Jul 13.

PMID:
21745721
33.

The potential economic impact of restricted access to angiotensin-receptor blockers.

Guertin JR, Jackevicius CA, Cox JL, Humphries K, Pilote L, So DY, Tu JV, Wijeysundera H, Rinfret S; Canadian Cardiovascular Outcomes Research Team.

CMAJ. 2011 Feb 22;183(3):E180-6. doi: 10.1503/cmaj.100787. Epub 2011 Jan 24.

34.

Analysis of willingness to pay for implantable cardioverter-defibrillator therapy.

Nowakowska D, Guertin JR, Liu A, Abrahamowicz M, Lelorier J, Lespérance F, Brophy JM, Rinfret S.

Am J Cardiol. 2011 Feb 1;107(3):423-7. doi: 10.1016/j.amjcard.2010.09.041.

PMID:
21257009
35.

Willingness to pay to eliminate the risk of restenosis following percutaneous coronary intervention: a contingent valuation.

Guertin JR, Liu A, Abrahamowicz M, Cohen DJ, Ismail S, LeLorier J, Brophy JM, Rinfret S.

Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):46-52. doi: 10.1161/CIRCOUTCOMES.109.915421. Epub 2010 Dec 14.

PMID:
21156881

Supplemental Content

Loading ...
Support Center